Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial
Authors:
Top Cited Papers
- 1 November 2017
- journal article
- research article
- Published by Elsevier in The Lancet Oncology
- Vol. 18 (11) , 1493-1501
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- A Pilot Study of Anti-CTLA4 Antibody Ipilimumab in Patients with Synovial SarcomaSarcoma, 2013
- Immunologic Correlates of the Abscopal Effect in a Patient with MelanomaNew England Journal of Medicine, 2012
- Tumor Regression in Patients With Metastatic Synovial Cell Sarcoma and Melanoma Using Genetically Engineered Lymphocytes Reactive With NY-ESO-1Journal of Clinical Oncology, 2011
- Pro‐inflammatory chemokine–chemokine receptor interactions within the Ewing sarcoma microenvironment determine CD8+ T‐lymphocyte infiltration and affect tumour progressionThe Journal of Pathology, 2010
- Addition of muramyl tripeptide to chemotherapy for patients with newly diagnosed metastatic osteosarcomaCancer, 2009
- A high proportion of bone marrow T cells with regulatory phenotype (CD4+CD25hiFoxP3+) in Ewing sarcoma patients is associated with metastatic diseaseInternational Journal of Cancer, 2009
- Prognostic significance of HLA class I expression in osteosarcoma defined by anti‐pan HLA class I monoclonal antibody, EMR8‐5Cancer Science, 2006
- Expression of HLA‐A, B, C, β2‐microglobulin (β2m), HLA‐DR, ‐DP, ‐DQ and of HLA‐D‐associated invariant chain (Ii) in soft‐tissue tumorsInternational Journal of Cancer, 1990
- Experience with the Use of High-Dose Interleukin-2 in the Treatment of 652 Cancer PatientsAnnals of Surgery, 1989
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958